Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

Lcrazylegs84 (22.72) Submitted: 10/1/2011 1:06:09 AM : Start Price: $3.50 ACUR Score: -26.87

going up

thebigpicture37 (< 20) Submitted: 6/22/2011 11:47:13 AM : Start Price: $3.97 ACUR Score: -22.12

The 20 million royalty will be paid to Acura Pharma in late June or early July. Also Pfizer plans to partner with Acura on other opioid drugs using the Aversion TM technology. However my favorite is an OTC product with pseudoephedrine which will be rolled out later this year. Nexafed TM using Impede TM technology. This drug will have the same ingredients as Sudafed TM and brand name.

KimLanners (< 20) Submitted: 6/20/2011 10:53:32 AM : Start Price: $4.98 ACUR Score: -40.39

fda approval

pyupie0216 (22.31) Submitted: 8/18/2010 5:55:20 PM : Start Price: $2.44 ACUR Score: -8.42

screen

steelersnextat7 (< 20) Submitted: 9/22/2009 2:10:56 AM : Start Price: $4.88 ACUR Score: -59.08

FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up

manvsmonkey (77.32) Submitted: 7/28/2008 2:09:10 PM : Start Price: $7.30 ACUR Score: -67.23

seems like the phase III trial is going well

http://seekingalpha.com/article/87373-a-biotech-bloom-in-july?source=side_bar_long_ideas

davidr825 (< 20) Submitted: 6/13/2008 7:58:39 PM : Start Price: $9.54 ACUR Score: -68.26

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical